
NYSEHealthcareMedical - Diagnostics & Research
最新数据
US$435.84
−US$0.59 · -0.14%
Waters Corporation is a global leader in specialized measurement, delivering analytical solutions across Asia, the Americas, and Europe. The company operates through two main divisions: Waters and TA. Under its Waters segment, it engineers, manufactures, sells, and provides support for high and ultra-performance liquid chromatography and mass spectrometry (MS) systems. This includes essential consumables like chromatography columns and comprehensive post-warranty service plans. The TA segment focuses on designing, producing, selling, and servicing instruments for thermal analysis, rheometry, and calorimetry. Additionally, Waters develops and supplies sophisticated software that integrates with both its own instruments and those from other manufacturers. The company's advanced MS technology plays a crucial role in various applications, such as drug discovery and development (including clinical trial assessments), analyzing proteins involved in disease processes, ensuring nutritional safety, and conducting environmental testing. Its thermal analysis, rheometry, and calorimetry instruments are vital for assessing the suitability and stability of a wide range of materials, including fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids. These instruments support diverse sectors like industrial manufacturing, consumer goods, healthcare products, and life science research. Waters' extensive client base spans the life sciences, pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental sectors, where its products are instrumental in research and development, quality assurance, and general laboratory operations. Established in 1958, Waters Corporation is headquartered in Milford, Massachusetts.
前收盘价
US$435.84
−US$0.59 · -0.14%
盘前
US$432.01
−US$3.83 · -0.88%
10月8日 9:21 ET
盘中时间采用ET。市场数据可能有所延迟。
Waters Corporation is a global leader in specialized measurement, delivering analytical solutions across Asia, the Americas, and Europe. The company operates through two main divisions: Waters and TA. Under its Waters segment, it engineers, manufactures, sells, and provides support for high and ultra-performance liquid chromatography and mass spectrometry (MS) systems. This includes essential consumables like chromatography columns and comprehensive post-warranty service plans. The TA segment focuses on designing, producing, selling, and servicing instruments for thermal analysis, rheometry, and calorimetry. Additionally, Waters develops and supplies sophisticated software that integrates with both its own instruments and those from other manufacturers. The company's advanced MS technology plays a crucial role in various applications, such as drug discovery and development (including clinical trial assessments), analyzing proteins involved in disease processes, ensuring nutritional safety, and conducting environmental testing. Its thermal analysis, rheometry, and calorimetry instruments are vital for assessing the suitability and stability of a wide range of materials, including fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids. These instruments support diverse sectors like industrial manufacturing, consumer goods, healthcare products, and life science research. Waters' extensive client base spans the life sciences, pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental sectors, where its products are instrumental in research and development, quality assurance, and general laboratory operations. Established in 1958, Waters Corporation is headquartered in Milford, Massachusetts.
日内区间
当前US$435.84
52周区间
当前US$435.84
盈利能力占已公布营收的百分比。
营收
营业利润
净利润
| 项目(USD) | 2025财年 | 2024财年 | 2023财年 | 2022财年 | 2021财年 |
|---|---|---|---|---|---|
| 营收 | 31.65亿 USD | 29.58亿 USD | 29.56亿 USD | 29.72亿 USD | 27.86亿 USD |
| 销货成本 | 13.37亿 USD | 12亿 USD | 11.95亿 USD | 12.48亿 USD | 11.57亿 USD |
| 毛利 | 18.29亿 USD | 17.58亿 USD | 17.61亿 USD | 17.24亿 USD | 16.29亿 USD |
| 研究与开发 | 1.95亿 USD | 1.83亿 USD | 1.75亿 USD | 1.76亿 USD | 1.68亿 USD |
| 销售、一般及管理费用 | 7.4亿 USD | 6.9亿 USD | 7.36亿 USD | 6.58亿 USD | 6.27亿 USD |
| 营业费用 | 9.35亿 USD | 9.32亿 USD | 9.44亿 USD | 8.5亿 USD | 8.08亿 USD |
| 利息收入 | 738.9万 USD | 1741.6万 USD | 1662.1万 USD | 1102万 USD | 1222.1万 USD |
| 利息支出 | 6954.8万 USD | 8967.7万 USD | 9886.1万 USD | 4879.7万 USD | 4493.8万 USD |
| 折旧和摊销 | 2.06亿 USD | 1.92亿 USD | 1.66亿 USD | 1.3亿 USD | 1.32亿 USD |
| 营业利润 | 8.93亿 USD | 8.26亿 USD | 8.18亿 USD | 8.73亿 USD | 8.22亿 USD |
| 净利润 | 6.43亿 USD | 6.38亿 USD | 6.42亿 USD | 7.08亿 USD | 6.93亿 USD |
公司数据更新于 2026年10月8日。
近期已公布业绩
近期已公布业绩
第三方分析师预期可能变化,并非 GoAI 建议。
平均目标
US$453.5
上涨空间 4.05%| 行动 | 除息日 | 详情 | 记录日期 | 付款日期 |
|---|---|---|---|---|
股息 | 1996年11月26日 | US$0.16Irregular | — | — |
除息 1996年11月26日
US$0.16
Irregular
报告持有此股票敞口的交易所交易基金。
State Street SPDR S&P 500 ETF1557.T825.23亿0.06%129.41万亿 JPY0.09%JP¥122,700-0.57%
Vanguard Morningstar Total Stock Market ETFVTI12.94亿0.06%2.3万亿 USD0.03%US$381.03-0.40%
Vanguard S&P 500 ETFVOO10.82亿0.06%1.8万亿 USD0.03%US$714.34-0.26%
Vanguard Morningstar Mid-Cap ETFVO8.81亿0.39%2264亿 USD0.03%US$80.14-1.04%
iShares Core S&P 500 ETFIVV5.71亿0.06%8996.25亿 USD0.03%US$780.58-0.25%
State Street SPDR S&P 500 ETFSPY5.21亿0.06%8190.39亿 USD0.09%US$777.22-0.24%
Vanguard Morningstar Mid-Cap Growth ETFVOT3.13亿0.91%341亿 USD0.05%US$300.18-1.27%
State Street Health Care Select Sector SPDR ETFXLV3.05亿0.71%431.09亿 USD0.08%US$168.81+1.03%
State Street SPDR S&P 500 ETF1557.T
Vanguard Morningstar Total Stock Market ETFVTI
Vanguard S&P 500 ETFVOO
Vanguard Morningstar Mid-Cap ETFVO
iShares Core S&P 500 ETFIVV
State Street SPDR S&P 500 ETFSPY
Vanguard Morningstar Mid-Cap Growth ETFVOT
State Street Health Care Select Sector SPDR ETFXLVAI 生成内容及延迟市场数据仅供信息与教育用途,不构成投资建议。